ORIGINAL ARTICLE
REVISTA DE LA FACULTAD DE MEDICINA HUMANA 2024 - Universidad Ricardo Palma
1 School of Medicine. Universidad César Vallejo. Trujillo, Peru
2 Hospital III de Emergencias Grau (EsSalud). Lima, Perú.
a Professor at the School of Medicine
b Medical Doctor Specialist in General Surgery
c Academic Degree of Doctor in Medicine
ABSTRACT
Introduction: The clinical, etiological, anatomical and pathophysiological classification (CEAP)
standardizes the manifestations of lower limb venous disease.
Objetive: To investigate the association between insufficient venous systems and the clinical
classification of CEAP.
Method: A quantitative, cross-sectional, analytical, correlational design was carried out.
Non-probability sampling for convenience. Sample size was 136 lower limbs from 71 patients. Chi-square,
Monte Carlo and Odd ratio (OR) statistical tests were used with 95% confidence intervals through
bivariate logistic regression (p<0.05).
Results: 71.8% were female, average age of 66.1. The most frequent insufficient venous system was
the superficial one (61.7%). 100% of the dilated great saphenous veins (GSV) had insufficiency. The most
frequent CEAP clinical class was C2: 44.9%); 35.1% of C1 (telangiectasia) had an insufficient venous
system and 50% of C2 had GSV insufficiency (p=0.227). There was an association between insufficiency of
the superficial and deep venous systems and the CEAP clinical classification (p=<0.001). The deep
venous
system was associated with severe chronic venous disease of the lower limbs OR (6.04) with 95% CI
(1.02-35.73) and p=0.047.
Conclusions: An association was evident between the insufficiency of the superficial and deep
venous systems with the clinical classification of CEAP. One third of lower limbs with C1
(telangiectasias) had an insufficient venous system.
Keywords: Varicose veins, Doppler ultrasonography, lower limbs, veins (source: MeSH NLM)
RESUMEN
Introducción: La clasificación clínica, etiológica, anatómica y fisiopatológica (CEAP)
estandariza
las manifestaciones de la enfermedad venosa de miembros inferiores.
Objetivo: Investigar la asociación entre los sistemas venosos insuficientes y la clasificación
clínica del CEAP.
Método: Se realizó una investigación tipo cuantitativa, transversal, con diseño analítico,
correlacional. El muestreo es no probabilístico por conveniencia. El tamaño de muestra fue136 miembros
inferiores de 71 pacientes. Se utilizó las pruebas estadísticas de Chi-cuadrado, Monte Carlo y Odd ratio
(OR) con intervalos de confianza del 95 %, mediante regresión logística bivariada (p<0,05).
Resultados: El 71,8 % fue femenino con edad media de 66,1. El sistema venoso insuficiente más
frecuente fue el superficial: 61,7 %. El 100% de las venas safenas mayores (VSM) dilatadas tenían
insuficiencia. La clase clínica CEAP más frecuente fue la C2: 44,9 %; el 35,1 % de C1
(telangiectasia) tenían un sistema venoso insuficiente; el 50 % de C2, insuficiencia de la VSM
(p=0,227). Hubo una asociación entre la insuficiencia de los sistemas venosos superficial y profundo
y la clasificación clínica del CEAP (p=<0,001). El sistema venoso profundo estuvo asociado a la
enfermedad venosa crónica de miembros inferiores grave OR (6,04) con IC95 % (1,02-35,73) y p=0,047.
Conclusiones: Se evidenció una asociación entre la insuficiencia de los sistemas venosos
superficial y profundo con la clasificación clínica del CEAP. Un tercio de los miembros
inferiores con C1 (telangiectasias) tenían un sistema venoso insuficiente.
Palabras clave: Varices, ecografía Doppler, miembros inferiores, venas (fuente: DeCS BIREME)
INTRODUCTION
Chronic Venous Disease of the Lower Limbs (CVDLL) encompasses any morphological or functional
abnormality of the venous system, as opposed to Chronic Venous Insufficiency (CVI), which is diagnosed
solely based on functional abnormalities using venous Doppler ultrasonography (1,
2). CVDLL is
characterized by venous hypertension and stasis, resulting from valvular incompetence and/or venous flow
obstruction. Superficial venous reflux is the most common cause; the venous walls become structurally
weak, and the valves incompetent (3); however, it's unclear whether this
incompetence is the cause or
result of venous wall dilation (4). In deep veins, CVDLL occurs due to
post-thrombotic valvular changes
in 80% of cases and primary valvular insufficiency in 20% (5). Approximately
half of all CVI cases occur
at multiple levels or are combined (6).
CVDLL is the most common chronic vascular disease (7). Its prevalence is
difficult to estimate,
affecting 20-40% of the adult population (8), but this varies between
countries (9). Risk factors for
CVDLL include advanced age, female gender, obesity, pregnancy, multiparity, sedentary lifestyle, family
history of varicose veins, prolonged standing, smoking, elevated estrogen levels, among others (10, 11).
CVDLL is associated with a wide variety of clinical presentations, including telangiectasias, varicose
veins, pigmentation, edema, lipodermatosclerosis, and ulcers (12). To
address this complexity of
clinical manifestations of CVDLL, the American Venous Forum developed a Clinical, Etiological,
Anatomical, and Pathophysiological (CEAP) classification system in 1994 to provide a reliable and
reproducible classification of the many manifestations of CVDLL. This was modified in 2004 and is as
follows: C0: no visible signs of venous disease; C1: reticular veins or telangiectasias; C2: varicose
veins; C3: edema; C4: dermal signs, subdivided into C4a (pigmentation or eczema) and C4b
(lipodermatosclerosis or atrophie blanche); C5: healed ulcer; C6: active ulcer (13).
From a clinical perspective, this classification incorporates various signs and symptoms of chronic
venous disorders to characterize their severity. The classification ranges from asymptomatic patients to
those with recurrent or active venous leg ulcers (VLUs), where quality of life tends to decline, as
indicated by Silva et al. (14), due to pain, edema, poor sleep quality, and
depression (15, 16).
There are studies on the association between CVI and the CEAP clinical classification with varied
results (17 - 20). The justification for the current
study is that there are few studies on this topic in
the Peruvian population; moreover, the relationship between segmental reflux patterns in the great
saphenous vein (GSV) and the CEAP clinical classification has been little studied.
The main objective of the study was to investigate the association between insufficient venous systems
and the CEAP clinical classification in patients with chronic venous disease of the lower limbs, in
addition to demonstrating venous system insufficiency in telangiectasias.
METHODS
This was a quantitative, cross-sectional study with an analytical and correlational design. In the
venous Doppler ultrasound examination of the lower limbs, normal venous diameter measurements were taken
from the 2015 Argentine consensus among radiologists and phlebologists: for the great saphenous vein:
the saphenous ostium (opening) measures between 6 - 8 mm; the arch, between 5 - 6 mm; the saphenous
trunk, in the thigh, measures 3 - 4.5 mm and in the infrapatellar region, 3 mm. For the small saphenous
vein (SSV), the normal diameter is 1- 4 mm; the diameter of perforating veins is noted when it is ≥ 3 mm
(21). Regarding venous insufficiency or reflux, measurements were based on
the standards of the American
Society for Vascular Surgery from 2022, which defines reflux as a minimum value > 500 ms of reverse flow
in the superficial trunk veins - GSV, SSV (small saphenous vein), anterior accessory great saphenous
vein, posterior accessory great saphenous vein - and in the tibial, deep femoral, and perforating veins.
A minimum value > 1 second of reverse flow is diagnostic for reflux in the common femoral, femoral, and
popliteal veins (22).
The 2004 CEAP clinical classification was used to standardize the clinical evaluation of patients.
Additionally, CVDLL was classified as mild-moderate (C1-C3) and severe (C4-C6).
The population consisted of patients diagnosed with varicose veins of the lower limbs, with a venous
Doppler ultrasound report, treated in the General Surgery office of Hospital III de Emergencias Grau de
EsSalud, in the years 2022-2023. Inclusion criteria were patients over 18 years of age, with a clinical
class between C1-C6 of the CEAP classification; and exclusion criteria were patients with a surgical
history or sclerotherapy for varicose veins of the lower limbs, and those with neurological,
rheumatological problems, and presence or history of deep vein thrombosis. A non-probability convenience
sampling was conducted. The sample size was 136 lower limbs evaluated from 71 patients.
The data collection instrument was a data sheet with closed and open alternatives, which was reliable
and validated by a group of six medical experts who evaluated the relevance, consistency, and clarity of
each question. The technique of inspecting data records from electronic medical records was used to
compile the database.
Categorical variables were expressed as numbers with percentages, and the association between variables
was investigated using Pearson's Chi-square test or the Monte Carlo test, as appropriate. Odds ratios
(OR) with 95% confidence intervals (CI) were calculated using bivariate logistic regression, to
determine the association between Doppler ultrasound findings and severe CVDLL. A p-value of <0.05
was considered significant. Statistical analyses were performed using IBM SPSS Statistics 26.0 software.
This work complied with the Declaration of Helsinki II and the General Health Law. The study was
approved by the Ethics Committee of Hospital III de Emergencias Grau.
RESULTS
The study included 71 patients, of which 71.8% were women, with an average age of 66.1±12.1 years. The
most frequent age group was 71-80 years, representing 29.6% of the sample. The most common insufficient
venous system was the superficial system: 61.7%. All dilated great saphenous veins (GSV) had venous
insufficiency (p-value≤0.001, using the Chi-square test). 3.7% of the dilated small saphenous veins
(SSV) had venous insufficiency: p-value = 0.002, using the Monte Carlo test. See Table 1.
|
Insufficient GSV n (%) |
|
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dilated GSV |
Yes |
No |
Total |
||||||||||||
Yes |
45 (33,1) |
0 (0,0) |
45 (33,1) |
||||||||||||
No |
28 (20,6) |
63 (46,3) |
91 (66,9) |
||||||||||||
Total |
73 (53,7) |
63 (46,3) |
136 (100,0) |
||||||||||||
|
Insufficient SSV n (%) |
|
|||||||||||||
Dilated SSV |
Sí |
No |
Total |
||||||||||||
Yes |
5 (3,7) |
6 (4,4) |
11 (8,1) |
||||||||||||
No |
14 (10,3) |
111 (81,6) |
125 (91,9) |
||||||||||||
Total |
19 (14,0) |
117 (86,0) |
136 (100,0) |
GSV: Great Saphenous Vein, SSV: Small Saphenous Vein
The most frequent CEAP clinical class was C2, representing 44.9%, a group that mostly exhibited
insufficiency in both the superficial and deep venous systems. See table 2.
Insufficient venous system |
CEAP Clinical Class n (%) |
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C1 |
C2 |
C3 |
C4 |
C5 |
C6 |
||||||||||||||||||||||
Superficial |
6 (4,4) |
19 (14,0) |
5 (3,7) |
1 (0,7) |
1 (0,7) |
2 (1,5) |
|||||||||||||||||||||
Deep |
4 (2,9) |
1 (0,7) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
|||||||||||||||||||||
Perforating |
3 (2,2) |
2 (1,5) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
|||||||||||||||||||||
Superficial and Deep |
3 (2,2) |
21 (15,4) |
0 (0,0) |
1 (0,7) |
1 (0,7) |
3 (2,2) |
|||||||||||||||||||||
Superficial, Deep and Perforating |
1 (0,7) |
5 (3,7) |
0 (0,0) |
2 (1,5) |
2 (1,5) |
2 (1,5) |
|||||||||||||||||||||
Superficial and Perforating |
2 (1,5) |
6 (4,4) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
|||||||||||||||||||||
Deep and Perforating |
0 (0,0) |
2 (1,5) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
1 (0,7) |
|||||||||||||||||||||
None |
35 (25,7) |
5 (3,7) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
|||||||||||||||||||||
Total |
54 (39,7) |
61 (44,9) |
5 (3,7) |
4 (2,9) |
4 (2,9) |
8 (5,9) |
C: Clinical Class (p-value ≤0.001, using the Monte Carlo test)
39.7% of all evaluated lower limbs were C1 (telangiectasias); 35.1% of them had an insufficient venous
system. (See Table 3)
CEAP Clinical Class |
Insufficient Venous System n (%) |
||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Superficial |
Deep |
Perforating |
Superficial and deep |
Superficial, deep and perforating |
Superficial and perforating |
Deep and perforating |
None |
||||||||||||||||||||||||||||
C1 (n=54) |
6 (11,1) |
4 (7,4) |
3 (5,5) |
3 (5,5) |
1 (1,8) |
2 (3,7) |
0 (0,0) |
35 (64,8) |
In the saphenous veins, it was found that 44.1% of cases had insufficiency of the GSV; 3.7% of the SSV
and 9.6% of both saphenous veins. In lower limbs with CEAP C2, half had GSV insufficiency. (See Table 4)
Incompetent segment of saphenous vein |
CEAP Clinical Class n (%) |
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C1 |
C2 |
C3 |
C4 |
C5 |
C6 |
||||||||||||||||||||||
GSV |
9 (11,5) |
39 (50,0) |
4 (5,1) |
3 (3,8) |
2 (2,6) |
3 (3,8) |
|||||||||||||||||||||
SSV |
0 (0,0) |
4 (5,1) |
1 (1,3) |
0 (0,0) |
0 (0,0) |
0 (0,0) |
|||||||||||||||||||||
GSV + SSV |
1 (1,3) |
6 (7,7) |
0 (0,0) |
1 (1,3) |
2 (2,6) |
3 (3,8) |
|||||||||||||||||||||
Total (n=78) |
10 (12,8) |
49 (62,8) |
5 (6,4) |
4 (5,1) |
4 (5,1) |
6 (7,7) |
GSV: Great Saphenous Vein; SSV: Small Saphenous Vein; p-value = 0.227, using the Monte Carlo test
As shown in Table 5, there is a significant association between the CEAP clinical classification and the
insufficiency of the SFJ, superficial and deep venous systems.
Insufficient Venous System |
CEAP Clinical Classification n (%) |
p value |
|||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C1 |
C2 |
C3 |
C4 |
C5 |
C6 |
||||||||||||||||||||||||||
SFJ |
2 (1,5) |
34 (25,0) |
4 (2,9) |
3 (2,2) |
3 (2,2) |
3 (2,2) |
<0,001a |
||||||||||||||||||||||||
Superficial |
13 (9,6) |
51 (37,5) |
5 (3,7) |
4 (2,9) |
4 (2,9) |
7 (5,1) |
<0,001a |
||||||||||||||||||||||||
Deep |
8 (5,9) |
29 (21,3) |
0 (0,0) |
3 (2,2) |
3 (2,2) |
6 (4,4) |
<0,001a |
||||||||||||||||||||||||
Perforating |
7 (5,1) |
15 (11,0) |
0 (0,0) |
2 (1,5) |
2 (1,5) |
3 (2,2) |
0,103a |
SFJ: Saphenofemoral Junction; p-value ≤ 0.05 was considered statistically significant, using the Monte Carlo test.
RESULTS
66.7% of lower limbs with mild-moderate CVDLL had great saphenous vein (GSV) insufficiency and 9.0% had
insufficiency in both saphenous veins. 7.7% of lower limbs with severe CVDLL had insufficiency in both
saphenous veins, with a p-value of 0.011 and assessed by the Monte Carlo test. 50.7% of lower limbs with
mild-moderate CVDLL had superficial venous system insufficiency, with a p-value of 0.005 and assessed by
the Chi-square test. 29.4% of lower limbs with mild-moderate CVDLL had saphenofemoral junction (SFJ)
insufficiency, with a p-value of 0.073 and assessed by the Chi-square test. 27.2% of lower limbs with
mild-moderate CVDLL had deep venous system insufficiency, with a p-value of 0.001 and assessed by the
Chi-square test. 16.2% of lower limbs with mild-moderate CVDLL had perforating venous system
insufficiency, with a p-value of 0.020 and assessed by the Monte Carlo test.
As shown in Table 6, ultrasound findings showed a significant association between severe CVDLL and deep
venous system insufficiency.
Insufficient Venous System |
Odds ratio (95% CI)a |
p-value |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Superficial |
7,52 (0,79-71,64) |
0,079 |
|||||||||
Deep |
6,04 (1,02-35,73) |
0,047 |
|||||||||
Perforating |
3,72 (0,73-18,93) |
0,113 |
CI: Confidence Interval; p < 0.05 was considered statistically significant; the regression was bivariate logistic.
DISCUSSION
This study demonstrated the predominance of the female gender in CVDLL, consistent with other authors
(5, 17, 23). The superficial venous
system was the most frequently insufficient system; GSV was the most
affected, similar to Taengsakul (5); GSV reflux was the most common in their
study population. Andaç N
et al. (18) observed that the most common segment of GSV with reflux was
above the knee. Kanchanabat et
al. (19) noted that although GSV reflux was present in most patients with
lower limb CVI, SSV reflux
could occur in a third of patients, especially those with lateral ulceration.
In this study, all dilated GSV and nearly half of the dilated SSV were insufficient, consistent with
Choi et al. (24), who found that GSV and SSV diameters were significantly
larger in patients with
reflux, concluding that although vein diameter cannot be used as an absolute reference for venous
reflux, it may have predictive value in patients with varicose veins. Kim et al. (12) reported that this
relationship was only evident in the lower part of the thigh; Yang et al. (9) found that mean GSV
diameters correlated with CEAP progression, but with SSV, the disease progression was less clear.
In this study, the most common clinical category was C2: 44.8%, which aligns with Taengsakul (5) at 39%,
unlike Porciunculla et al. (7), who found C3 as the most frequent category
at 60%.
It was found that a third of the CEAP clinical class C1 had venous system insufficiency, of which 12.8%
was of the saphenous veins, similar to Hong (17), who found a 19.2%
prevalence of saphenous vein
incompetence in CEAP C1 limbs; additionally, a considerable number of limbs without varices had
incompetent saphenous veins.
In this study, 44.1% of lower limbs had GSV insufficiency, 3.6% SSV, and 9.5% both, similar to Hong
(17), who reported 71% GSV reflux; 11.9% SSV reflux, and 17.1% both GSV and
SSV; however, Kanchanabat et
al. (19) reported 47.2% GSV reflux; 8.1% SSV reflux, and 25.6% both. Yilmaz
et al. (23) reported that
the most common reflux pattern in patients with GSV insufficiency involved the SFJ with competent
malleolar region: 48.9%.
The study showed a relationship between SFJ incompetence and CEAP clinical class, unlike Porciunculla et
al. (7), who found no relationship, but Hong (17) did show the correlation between incompetent SFJ and
the distribution of incompetent segments in the GSV.
This work found deep venous system insufficiency in 75.5% of mild-moderate grades, much higher than
Taengsakul (5): 57.8%. Hong (17) reported that
among limbs with deep venous system insufficiency, 98%
had popliteal vein insufficiency and 2% femoral vein insufficiency.
This study did not find an association between perforating venous system insufficiency and the CEAP
clinical category. Tolu et al. (6) found that varicose veins of lower limbs
were related to perforating
vein insufficiency in 44.7% of cases and observed a significant relationship between increased diameter
of the perforating vein and the presence of perforating vein insufficiency. Huang et al. (20) found that
incompetent perforating veins are a significant risk factor for dermal pigmentation.
One of the limitations of the study was the lack of uniformity in the Doppler reports, which prevented
the analysis of other data such as reflux velocity, etc. The strength was that each venous system and
its relationship with the clinical category were studied. It is suggested to conduct research on lower
limb venous insufficiency in the Peruvian population using other classification systems such as HASTI
and the Venous Clinical Severity Score, which are used to assess severity, quantify progression, and
treatment outcomes of patients with CVI (2, 9).
CONCLUSIONS
There is an association between the insufficiency of both superficial and deep venous systems and the
CEAP clinical classification. One third of the lower limbs with CEAP clinical class C1 (telangiectasias)
showed insufficiency of a venous system.
Authorship contributions:
HJMR participated in the conceptualization, research, methodology, resources, and writing of
the original draft.
Financing:
Self-financed.
Declaration of conflict of interest:
The author declares no conflict of interest.
Recevied:
October 23, 2023
Approved:
March 16, 2024
Correspondence author:
Hubert James Mendoza Rojas.
Address:
Av. Grau 351, Cercado de Lima. Lima-Peru.
Phone:
(+51) 992758186
E-mail:
hmendozaro@ucvvirtual.edu.pe
Article published by the Journal of the faculty of Human Medicine of the Ricardo Palma University. It is an open access article, distributed under the terms of the Creatvie Commons license: Creative Commons Attribution 4.0 International, CC BY 4.0 (https://creativecommons.org/licenses/by/1.0/), that allows non-commercial use, distribution and reproduction in any medium, provided that the original work is duly cited. For commercial use, please contact revista.medicina@urp.edu.pe.